Luis A. Brito

5.6k total citations · 5 hit papers
24 papers, 3.6k citations indexed

About

Luis A. Brito is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Luis A. Brito has authored 24 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Luis A. Brito's work include Immunotherapy and Immune Responses (13 papers), RNA Interference and Gene Delivery (9 papers) and Influenza Virus Research Studies (5 papers). Luis A. Brito is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), RNA Interference and Gene Delivery (9 papers) and Influenza Virus Research Studies (5 papers). Luis A. Brito collaborates with scholars based in United States, Switzerland and Sweden. Luis A. Brito's co-authors include Derek T. O’Hagan, Kimberly J. Hassett, Manmohan Singh, Giuseppe Ciaramella, Olga Yuzhakov, Örn Almarsson, Andrew J. Geall, Jeffrey B. Ulmer, Kapil Bahl and Ruchi R. Shah and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Scientific Reports.

In The Last Decade

Luis A. Brito

24 papers receiving 3.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines

2019 601 citations Kimberly J. Hassett, Kerry E. Benenato et al. Molecular Therapy — Nucleic Acids profile →
Nonviral delivery of self-amplifying RNA vaccines

2012 525 citations Andrew J. Geall, Gillis R. Otten et al. profile →
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

2017 493 citations Kapil Bahl, Olga Yuzhakov et al. Molecular Therapy profile →
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity

2021 256 citations Kimberly J. Hassett, Jaclyn S. Higgins et al. Journal of Controlled Release profile →
Novel approaches for vaccine development

2021 220 citations Makda S. Gebre, Luis A. Brito et al. Cell profile →

Peers

Countries citing papers authored by Luis A. Brito

Since Specialization

Citations

This map shows the geographic impact of Luis A. Brito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis A. Brito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis A. Brito more than expected).

Fields of papers citing papers by Luis A. Brito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis A. Brito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis A. Brito. The network helps show where Luis A. Brito may publish in the future.

Co-authorship network of co-authors of Luis A. Brito

This figure shows the co-authorship network connecting the top 25 collaborators of Luis A. Brito. A scholar is included among the top collaborators of Luis A. Brito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis A. Brito. Luis A. Brito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of lipid nanoparticle size on mRNA vaccine immunogenicity breakdown → 2021 ·Journal of Controlled Release ·Kimberly J. Hassett, Jaclyn S. Higgins, Angela Woods, Becca R. Levy, Yan Xia, Chiaowen Joyce Hsiao, Edward P. Acosta, Örn Almarsson, Melissa J. Moore, Luis A. Brito	256
2	Novel approaches for vaccine development breakdown → 2021 ·Cell ·Makda S. Gebre, Luis A. Brito, Lisa H. Tostanoski, Darin K. Edwards, Andrea Carfı́, Dan H. Barouch	220
3	The droplet size of emulsion adjuvants has significant impact on their potency, due to differences in immune cell-recruitment and -activation 2019 ·Scientific Reports ·Ruchi R. Shah, Marianna Taccone, Elisabetta Monaci, Luis A. Brito, Alessandra Bonci, Derek T. O’Hagan, Mansoor M. Amiji, Anja Seubert	33
4	Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines breakdown → 2019 ·Molecular Therapy — Nucleic Acids ·Kimberly J. Hassett, Kerry E. Benenato, Eric Jacquinet, (unknown), Angela Woods, Olga Yuzhakov, Sunny Himansu, (unknown), Benjamin Geilich, Tatiana Ketova, Cosmin Mihai, (unknown), Iain J. McFadyen, Melissa J. Moore, Joseph J. Senn, (unknown), Örn Almarsson, Giuseppe Ciaramella, Luis A. Brito	601
5	Stable Nanoemulsions for the Delivery of Small Molecule Immune Potentiators 2018 ·Journal of Pharmaceutical Sciences ·(unknown), Luis A. Brito, Tom Wu, Andrew T. Miller, Gillis R. Otten, Manmohan Singh, Derek T. O’Hagan	9
6	Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses breakdown → 2017 ·Molecular Therapy ·Kapil Bahl, (unknown), Olga Yuzhakov, Alex Bulychev, Luis A. Brito, Kimberly J. Hassett, Michael E. Laska, Mike Smith, Örn Almarsson, James D. Thompson, (unknown), Michael Watson, Tal Zaks, Giuseppe Ciaramella	493
7	Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells 2017 ·Frontiers in Immunology ·Gustaf Lindgren, Sebastian Ols, Frank Liang, Elizabeth A. Thompson, Ang Lin, Fredrika Hellgren, Kapil Bahl, Shinu John, Olga Yuzhakov, Kimberly J. Hassett, Luis A. Brito, Hugh Salter, Giuseppe Ciaramella, Karin Loré	102
8	Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques 2017 ·Molecular Therapy ·Frank Liang, Gustaf Lindgren, Ang Lin, Elizabeth A. Thompson, Sebastian Ols, (unknown), Shinu John, Kimberly J. Hassett, Olga Yuzhakov, Kapil Bahl, Luis A. Brito, Hugh Salter, Giuseppe Ciaramella, Karin Loré	274
9	Overview of Vaccine Adjuvants: Introduction, History, and Current Status 2016 ·Methods in molecular biology ·Ruchi R. Shah, Kimberly J. Hassett, Luis A. Brito	93
10	The Development of Self-Emulsifying Oil-in-Water Emulsion Adjuvant and an Evaluation of the Impact of Droplet Size on Performance 2015 ·Journal of Pharmaceutical Sciences ·Ruchi R. Shah, Stephanie Dodd, Mary Schaefer, Mildred Ugozzoli, Manmohan Singh, Gillis R. Otten, Mansoor M. Amiji, Derek T. O’Hagan, Luis A. Brito	39
11	Self-Amplifying mRNA Vaccines 2014 ·Advances in genetics ·Luis A. Brito, Sushma Kommareddy, Domenico Maione, Yasushi Uematsu, Cinzia Giovani, Francesco Berlanda Scorza, Gillis R. Otten, Dong Yü, Christian W. Mandl, Peter W. Mason, Philip R. Dormitzer, Jeffrey B. Ulmer, Andrew J. Geall	142
12	Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines 2014 ·Expert Opinion on Drug Delivery ·Raquel P. Deering, Sushma Kommareddy, Jeffrey B. Ulmer, Luis A. Brito, Andrew J. Geall	132
13	Designing and building the next generation of improved vaccine adjuvants 2014 ·Journal of Controlled Release ·Luis A. Brito, Derek T. O’Hagan	116
14	Vaccine adjuvant formulations: A pharmaceutical perspective 2013 ·Seminars in Immunology ·Luis A. Brito, Padma Malyala, Derek T. O’Hagan	126
15	Generation of a parvovirus B19 vaccine candidate 2013 ·Vaccine ·Sumana Chandramouli, Angelica Medina-Selby, Doris Coit, Mary Schaefer, (unknown), Luis A. Brito, Pu Zhang, Gillis R. Otten, Christian W. Mandl, Peter W. Mason, Philip R. Dormitzer, Ethan C. Settembre	55
16	Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies 2012 ·Vaccine ·Rebecca J. Loomis, Anders Lilja, James E. Monroe, (unknown), Luis A. Brito, Giuseppe Palladino, Michael Franti, Christian W. Mandl, Susan W. Barnett, Peter W. Mason	35
17	An alternative renewable source of squalene for use in emulsion adjuvants 2011 ·Vaccine ·Luis A. Brito, (unknown), Barbara C. Baudner, Simona Gallorini, George França dos Santos, Derek T. O’Hagan, Manmohan Singh	29
18	Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis 2010 ·BioMedical Engineering OnLine ·Luis A. Brito, (unknown), Steven R. Little, Mansoor M. Amiji	33
19	COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research 2010 ·Journal of Pharmaceutical Sciences ·Luis A. Brito, Manmohan Singh	160
20	In vitro and In vivo studies of local arterial gene delivery and transfection using lipopolyplexes‐embedded stents 2009 ·Journal of Biomedical Materials Research Part A ·Luis A. Brito, (unknown), Steven R. Little, Mansoor M. Amiji	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact